Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial
PaperCitations, authors & open-access status
Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 72 citations, 2011 year and closed oa status.
72
Citations
2011
Year
closed
OA Status